| Glenda Schweitzer, LADC | |
|
38 Old Ridgebury Rd, Danbury, CT 06810-5128 | |
| (203) 792-4515 | |
| (203) 748-2604 |
| Full Name | Glenda Schweitzer |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 38 Old Ridgebury Rd, Danbury, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083018097 | NPI | - | NPPES |
| 1174607253 | Other | CT | MIDWESTERN CONNECTICUT COUNCIL ON ALCOHOLISM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 1101 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Glenda Schweitzer, LADC 38 Old Ridgebury Rd, Danbury, CT 06810-5128 Ph: (203) 792-4515 | Glenda Schweitzer, LADC 38 Old Ridgebury Rd, Danbury, CT 06810-5128 Ph: (203) 792-4515 |
News Archive
Prospective students, lifelong learners, or anyone simply interested in patient safety can get a thorough overview of the topic and a taste of the Johns Hopkins educational experience beginning June 3.
Allegro Diagnostics, a leader in the field of molecular diagnostics for lung cancer, has announced that its clinical study for BronchoGen(TM), a diagnostic test for patients suspected of having lung cancer, will receive up to $2.8 million in funding for a Phase I/II Fast Track Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI).
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.
A study has revealed that a single fault in a gene that normally helps the body to repair its DNA increases a woman's risk of ovarian cancer six-fold. One in every 11 women who carry the faulty gene is likely to develop ovarian cancer at some point in her life compared with a typical risk of about one in 70 for women in the general population, scientists said.
One of the most vexing aspects of the COVID-19 pandemic is doctors' inability to predict which newly hospitalized patients will go on to develop severe disease, including complications that require the insertion of a breathing tube, kidney dialysis or other intensive care.
› Verified 5 days ago
Nick Nelson, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 75 West St, Danbury, CT 06810 Phone: 203-360-2889 Fax: 203-332-3271 | |
Haley Mozonski, Counselor Medicare: Medicare Enrolled Practice Location: 75 West St, Danbury, CT 06810 Phone: 203-748-5689 | |
Mrs. Carolyn Cunningham, LPC, NCC Counselor Medicare: Medicare Enrolled Practice Location: 72 North St, Suite 205, Danbury, CT 06810 Phone: 203-794-1044 Fax: 203-743-1110 | |
Ashley Seltzer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 75 West Street, Danbury, CT 06810 Phone: 203-205-2618 | |
Ms. Donna Gail Harrison-patton, MED Counselor Medicare: Not Enrolled in Medicare Practice Location: 75 West St, Danbury, CT 06810 Phone: 203-748-5689 | |
Mr. John Joseph Gordon, Jr., CASAC, ICADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 68 Virginia Ave, Unit 7, Danbury, CT 06810 Phone: 917-309-2067 | |
Amanda Ogrin, Counselor Medicare: Not Enrolled in Medicare Practice Location: 75 West St, Danbury, CT 06810 Phone: 203-748-5689 |